Ortega-Moreno Diego A, Dmytriw Adam A, Peña-Fuentes Adrián, Góngora-Rivera Fernando
Department of Neurology, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Monterrey, MEX.
Interventional Neuroradiology, St. Michael's Hospital, Toronto, CAN.
Cureus. 2025 Jul 23;17(7):e88616. doi: 10.7759/cureus.88616. eCollection 2025 Jul.
Endovascular management of ischemic stroke has been established as an effective treatment option. Nevertheless, restrictive selection criteria and limited device availability may delay recanalization in certain cases, particularly in developing countries. This report describes a resource-driven, off-label use of the Comaneci device in a patient with ischemic stroke presenting beyond the 24-hour window. A 61-year-old male arrived 28 hours after last known well (LKW). Despite initial clinical improvement with medical therapy alone, neurological deterioration occurred 2 days after onset. Primary aspiration thrombectomy achieved incomplete recanalization (mTICI 1, antegrade reperfusion but limited distal branch filling), revealing underlying intracranial atherosclerosis. Due to a lack of standard angioplasty tools, mechanical angioplasty with a Comaneci petit device was performed, improving perfusion to mTICI 2c (near complete perfusion except for slow flow or distal emboli). At 3-month follow-up, the patient had no residual symptoms and achieved full recovery (National Institutes of Health Stroke Scale (NIHSS) 0, mRS 0). Endovascular management remains a critical component of stroke care. Further exploration of alternative and adaptable strategies may help expand treatment access in challenging clinical settings.
缺血性卒中的血管内治疗已被确立为一种有效的治疗选择。然而,严格的选择标准和有限的设备可用性可能会在某些情况下延迟再通,特别是在发展中国家。本报告描述了在一名超出24小时时间窗就诊的缺血性卒中患者中,基于资源驱动对科马内奇装置进行的非标签使用。一名61岁男性在最后一次已知健康状态(LKW)后28小时就诊。尽管仅通过药物治疗最初临床症状有所改善,但发病2天后出现神经功能恶化。初次抽吸血栓切除术实现了不完全再通(改良脑梗死溶栓分级[mTICI] 1级,顺行再灌注但远端分支灌注受限),提示存在潜在的颅内动脉粥样硬化。由于缺乏标准的血管成形术工具,遂使用科马内奇小型装置进行机械血管成形术,将灌注改善至mTICI 2c级(除血流缓慢或远端栓塞外,近乎完全灌注)。在3个月的随访中,患者无残留症状,实现了完全康复(美国国立卫生研究院卒中量表[NIHSS]评分为0,改良Rankin量表[mRS]评分为0)。血管内治疗仍然是卒中治疗的关键组成部分。进一步探索替代和适应性策略可能有助于在具有挑战性的临床环境中扩大治疗机会。